Transcription factor HNF1beta and novel partners affect nephrogenesis.,
Dudziak K,Mottalebi N,Senkel S,Edghill EL,Rosengarten S,Roose M,Bingham C,Ellard S,Ryffel GU,
Kidney Int. July 1, 2008; 74(2):1523-1755.
|
|
Promoting ectopic pancreatic fates: pancreas development and future diabetes therapies.,
Pearl EJ,Horb ME,
Clin Genet. October 1, 2008; 74(4):1399-0004.
|
|
An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes.,
Marrero MB,Lucas R,Salet C,Hauser TA,Mazurov A,Lippiello PM,Bencherif M,
J Pharmacol Exp Ther. January 1, 2010; 332(1):1521-0103.
|
|
Micellar Nanomedicine of Novel Fatty Acid Modified Xenopus Glucagon-like Peptide-1: Improved Physicochemical Characteristics and Therapeutic Utilities for Type 2 Diabetes.,
Han J,Fei Y,Zhou F,Chen X,Zheng W,Fu J,
Mol Pharm. November 6, 2017; 14(11):1543-8392.
|
|
A comparative genomics study of carbohydrate/glucose metabolic genes: from fish to mammals.,
Zhang Y,Zhang Y,Qin C,Yang L,Lu R,Zhao X,Nie G,
BMC Genomics. April 11, 2018; 19(1):1471-2164.
|
|
Rational design of dimeric lipidated Xenopus glucagon-like peptide 1 analogues as long-acting antihyperglycaemic agents.,
Han J,Huang Y,Chen X,Zhou F,Fei Y,Fu J,
Eur J Med Chem. September 5, 2018; 157:1768-3254.
|
|
Inactivation of KCNQ1 potassium channels reveals dynamic coupling between voltage sensing and pore opening.,
Hou P,Eldstrom J,Shi J,Zhong L,McFarland K,Gao Y,Fedida D,Cui J,
Nat Commun. November 23, 2017; 8(1):2041-1723.
|
|
Glucocorticoid receptor is required for survival through metamorphosis in the frog Xenopus tropicalis.,
Sterner ZR,Shewade LH,Mertz KM,Sturgeon SM,Buchholz DR,
Gen Comp Endocrinol. May 15, 2020; 291:1095-6840.
|
|
Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study.,
Musale V,Moffett RC,Conlon JM,Flatt PR,Abdel-Wahab YH,
Peptides. February 1, 2021; 136:1873-5169.
|
|
Stapled, Long-Acting Xenopus GLP-1-Based Dual GLP-1/Glucagon Receptor Agonists with Potent Therapeutic Efficacy for Metabolic Disease.,
Han C,Sun Y,Yang Q,Zhou F,Chen X,Wu L,Sun L,Han J,
Mol Pharm. August 2, 2021; 18(8):1543-8392.
|
|
Genetic and Physiological Effects of Insulin on Human Urate Homeostasis.,
Mandal AK,Leask MP,Estiverne C,Choi HK,Merriman TR,Mount DB,
Front Physiol. January 1, 2021; 12:1664-042X.
|
|
Amphibian host-defense peptides with potential for Type 2 diabetes therapy - an updated review.,
Conlon JM,Owolabi BO,Flatt PR,Abdel-Wahab YHA,
Peptides. May 1, 2024; 175:1873-5169.
|
:
